SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

ACAD.O (ACAD.O) News

Track canonical SquawkNews coverage tagged to ACAD.O, ACAD.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol ACAD.O Asset market Sector Markets 90 days 1 Updated Sep 24, 2026, 11:01 AM UTC Open live news feed
L Acadia reports Phase 2 RADIANT topline results for remlifanserin in Alzheimer’s disease psychosis Acadia reported Phase 3-enabling topline results from the Phase 2 RADIANT study of remlifanserin in Alzheimer’s disease psychosis. The trial showed a modest efficacy signal at the higher dose, with the lower dose offerin NEWS | Sep 24, 2026, 11:01 AM UTC